This year, many alternative tobacco products such as low-nicotine or nicotine-free e-cigarettes have flooded the US retail market.
The United States Food and Drug Administration is currently considering the possibility of releasing a proposed regulation that would set maximum levels for nicotine content in cigarettes and other combustible tobacco products by 2023. The exact date is unknown as the FDA is currently drafting the proposed regulation.
However, there are already low-smoke and nicotine-free cigarettes on the market. 22nd Century Group's VLN King product and VLN Mint King cigarette have received Modified Risk Tobacco Product (MRTP) authorization, with a 95% reduction in nicotine content.
International industrial cannabis leader TAAT has released its zero-nicotine cigarettes made from the company's proprietary Beyond Tobacco blend, which replicates the sensory experience of smoking.
Lance Klatt, Executive Director of the Minnesota Service Station and Convenience Store Association, stated that regulatory issues must be considered first, and that innovative solutions should be sought in the tobacco industry.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
